COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,693 Articles (22,913 medRxiv, 8,780 bioRxiv)

Most recent first Previous |  Page 1286: Articles 12851-12860  | Next

Robust clinical detection of SARS-CoV-2 variants by RT-PCR/MALDI-TOF multi-target approach
Hernandez, M. M., Banu, R., Gonzalez-Reiche, A. S., van de Guchte, A., Khan, Z., Shrestha, P., Cao, L., Chen, F., Shi, H., Hanna, A., Alshammary, H., Fabre, S., Amoako, A., Obla, A., Alburquerque, B., Helena Patino, L., Ramirez, J. D., Sebra, R., Gitman, M. R., Nowak, M. D., Cordon-Cardo, C., Schutzbank, T. E., Simon, V., van Bakel, H., Sordillo, E. M., Paniz Mondolfi, A. E.
10.1101/2021.09.09.21263348 — Posted: 2021-09-16
SARS-CoV-2 anti-spike IgG antibody responses after second dose of ChAdOx1 or BNT162b2 in the UK general population
Wei, J., Pouwels, K. B., Stoesser, N., Matthews, P. C., Diamond, I., Studley, R., Rourke, E., Cook, D., Bell, J. I., Newton, J. N., Farrar, J., Howarth, A., Marsden, B. D., Hoosdally, S., Jones, E. Y., Stuart, D. I., Crook, D. W., Peto, T. E. A., Walker, A. S., Eyre, D. W.
10.1101/2021.09.13.21263487 — Posted: 2021-09-16
Synthetic lethality-based prediction of anti-SARS-CoV-2 targets
Pal, L. R., Cheng, K., Nair, N. U., Martin-Sancho, L., Sinha, S., Pu, Y., Riva, L., Yin, X., Schischlik, F., Lee, J. S., Chanda, S. K., Ruppin, E.
10.1101/2021.09.14.460408 — Posted: 2021-09-15
Intronization enhances expression of S-protein and other transgenes challenged by cryptic splicing
Tomberg, K., Antunes, L., Pan, Y., Hepkema, J., Garyfallos, D. A., Mahfouz, A., Bradley, A.
10.1101/2021.09.15.460454 — Posted: 2021-09-15
Molecular architecture of SARS-CoV-2 envelope by integrative modeling
Pezeshkian, W., Grunewald, F., Narykov, O., Lu, S., Wassenaar, T., Marrink, S.-J. J., Korkin, D.
10.1101/2021.09.15.459697 — Posted: 2021-09-15
Phylodynamic Pattern of Genetic Clusters, Paradigm Shift on Spatio-temporal Distribution of Clades, and Impact of Spike Glycoprotein Mutations of SARS-CoV-2 Isolates from India
Subramanian, S., Kitambi, S.
10.1101/2021.09.15.460506 — Posted: 2021-09-15
Interrogating COVID-19 Vaccine Hesitancy in the Philippines with a Nationwide Open-Access Online Survey
Caple, A., Dimaano, A., Sagolili, M. M., Uy, A. A., Aguirre, P. M., Alano, D. L., Camaya, G. S., Ciriaco, B. J., Clavo, P. J., Cuyugan, D., Fermo, C. F. G., Lanete, P. J., La Torre, A. J., Loteyro, T. A., Lua, R. M., Manansala, N. G., Mosquito, R. W., Octaviano, A. M., Orfanel, A. E., Pascual, G. M., Sale, A. J., Tendenilla, S. L., Trinidad, M. S., Trinidad, N. J., Verano, D. L., Austriaco, N.
10.1101/2021.09.11.21263428 — Posted: 2021-09-15
Efficacy of vaccination against severe COVID-19 in relation to Delta variant and time since second dose: the REACT-SCOT case-control study
McKeigue, P. M., McAllister, D., Hutchinson, S. J., Robertson, C., Stockton, D., Colhoun, H. M.
10.1101/2021.09.12.21263448 — Posted: 2021-09-15 Discussion: Onsite
Olfactory Bulb and Amygdala Gene Expression Changes in Subjects Dying with COVID-19
Piras, I. S., Huentelman, M., Walker, J., Arche, R., Glass, M., Vargas, D., Sue, L., Intorcia, A., Nelson, C., Suszczewicz, K., Borja, C., Desforges, M., Deture, M., Dicksond, D., Beach, T., Serrano, G.
10.1101/2021.09.12.21263291 — Posted: 2021-09-15
Robust induction of B cell and T cell responses by a third dose of inactivated SARS-CoV-2 vaccine
Liu, Y., Zeng, Q., Deng, C., Li, M., Li, L., Liu, D., Mei, J., Mo, R., Zhou, Q., Liu, M., Peng, S., Wang, J., Zhang, H., Xiao, H.
10.1101/2021.09.12.21263373 — Posted: 2021-09-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).